Clarissa Willett | Vice President, Investor Relations |
David King | Chairman & Chief Executive Officer |
Glenn Eisenberg | Executive Vice President & Chief Financial Officer |
John Ratliff | CEO, Covance Drug Development |
Lisa Gill | JPMorgan |
Jack Meehan | Barclays |
Kevin Caliendo | UBS |
Kevin Ellich | Craig-Hallum |
Ralph Giacobbe | Citi |
Bill Quirk | Piper Jaffray |
Erin Wright | Credit Suisse |
Eric Coldwell | Baird |
Donald Hooker | KeyBanc |
Mark Massaro | Canaccord |
Matt Larew | William Blair |
Derik De Bruin | Bank of America |
Ricky Goldwasser | Morgan Stanley |
Ladies and gentlemen, thank you for standing by. And welcome to the Q3 2019 LabCorp Holdings Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question-and-answer session [Operator Instructions]
I would now like to hand the conference over to our speaker, Clarissa Willett, VP of Investor Relations.